Race-based therapeutics Designer drug act criticised on race

被引：0
|
作者：
Walter, Patrick
机构：
来源：
CHEMISTRY & INDUSTRY | 2009年 / 02期
关键词：
D O I：
暂无
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [1] Race-based therapeutics
    Clyde W. Yancy
    Current Hypertension Reports, 2008, 10 : 276 - 285
  • [2] Race-based therapeutics
    Bloche, MG
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (20): : 2035 - 2037
  • [3] Race-based therapeutics
    Yancy, Clyde W.
    CURRENT HYPERTENSION REPORTS, 2008, 10 (04) : 276 - 285
  • [4] Race-based therapeutics
    Yancy C.W.
    Current Cardiovascular Risk Reports, 2007, 1 (2) : 108 - 117
  • [5] Physicians' attitudes regarding race-based therapeutics
    Frank, D.
    Gallagher, T. H.
    Cooper, L. A.
    Odunlami, B.
    Sellers, S.
    Price, E. G.
    Phillips, E.
    Bonham, V. L.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 : 155 - 156
  • [6] Race-based drugs
    Jordan, E
    NEW SCIENTIST, 2005, 186 (2505) : 26 - 26
  • [7] The implications of population admixture in race-based drug prescription
    Suarez-Kurtz, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (03) : 399 - 400
  • [8] Eliminating Race-Based Medicine
    Wright, Joseph L.
    Davis, Wendy S.
    Joseph, Madeline M.
    Ellison, Angela M.
    Heard-Garris, Nia J.
    Johnson, Tiffani L.
    PEDIATRICS, 2022, 150 (01)
  • [9] Race-Based Guidance and Nirsevimab
    Williams, Joshua T. B.
    Wu, Florence
    JAMA PEDIATRICS, 2025,
  • [10] Race-Based Medicine Is Racist
    DeZure, Chandani
    PEDIATRIC ANNALS, 2023, 52 (10): : E365 - E367
12345